FindTrial
Sign In

A clinical study to know the pattern of drug use against micro-organisms causing ventilator-associated pneumonia(VAP)and also to study the drug resistance(capacity of disease causing micro-organisms to withstand exposure to drugs) in patients who receive mechanical ventilation and develop VAP.

A clinical study on the pattern of antimicrobial drug use and drug resistance in patients with ventilator-associated pneumonia in a tertiary care hospital.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/12/016572
Enrollment
60
Registered
2018-12-10
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J17- Pneumonia in diseases classified elsewhere

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subjects of either gender, aged more than or equal to 18 years admitted as inpatients in Kempegowda Institute of Medical Sciences and Hospital, Bangalore, who receive mechanical ventilation and develop ventilator-associated pneumonia(VAP) 2. Willingness to give written informed consent

Exclusion criteria

Exclusion criteria: 1. Subjects in whom adequate sputum sample cannot be obtained 2. Subjects with viral, fungal or aspiration pneumonia 3. Subjects with tubercular(TB) pneumonia 4. Subjects who are sero-positive for HIV infection 5. Subjects with diagnosed malignancy 6. Subjects with pre-existing VAP 7. Subjects and/ or legal representatives not willing to give written informed consent

Design outcomes

Primary

MeasureTime frame
1.Duration of the patient on ventilator 2.Duration of hospital stay 3.30 day mortality Timepoint: Till the pneumonia is resolved or the patient is discharged from the hospital or for a period of 30 days, whichever is later.—

Secondary

MeasureTime frame
Clinical outcome parametersTimepoint: 1.Duration of the patient on Ventilator 2.Duration of hospital stay 3.30 day mortality—

Countries

India

Contacts

Public ContactDr Abisha Rezia R

Kempegowda Institute of Medical Sciences, Bangalore

vijendra_ramaiah@yahoo.co.in9980033334

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026